Sherman Diagnostics

Pathogen Detection Technology

Health Tech & Life Sciences
Active
Seed Ra'anana Founded 2020
Total raised
Last: Undisclosed 2024-05
Stage
Seed
Founded
2020
Headcount
1
HQ
Ra'anana
Sector
Health Tech & Life Sciences

About

Sherman Diagnostics has developed a diagnostic technology designed to detect pathogens using any biological sample. The company’s technology can be used for rapid testing of infectious diseases such as coronavirus economically and efficiently, enabling users to affordably detect DNA/RNA-based pathogens.

Funding history · 2 rounds · — total

2024-05
Undisclosed Undisclosed
2020-10
Undisclosed Undisclosed

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Sherman Diagnostics' core technology?
Sherman Diagnostics has developed a diagnostic technology designed to detect pathogens using any biological sample. This technology is intended for rapid and affordable testing of infectious diseases, including coronavirus, by detecting DNA/RNA-based pathogens.
When was Sherman Diagnostics founded?
Sherman Diagnostics was founded in March 2020.
Where is Sherman Diagnostics headquartered?
Sherman Diagnostics is headquartered in Ra'anana, Israel.
Which investor participated in Sherman Diagnostics' funding rounds?
Sanara Ventures has invested in Sherman Diagnostics in both October 2020 and May 2024.
What is the current employee count for Sherman Diagnostics?
Sherman Diagnostics currently has 1-10 employees.
What is Sherman Diagnostics' primary sector?
Sherman Diagnostics' primary sector is Health Tech & Life Sciences, with additional classifications in Medical Devices and Diagnostics Devices.
Who are the founders of Sherman Diagnostics?
The founders of Sherman Diagnostics are Menny Sherman and Eilon Sherman.
What is the product stage of Sherman Diagnostics' technology?
Sherman Diagnostics' product is currently in the 'released' stage.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesPatientsMedical Devices IndustryMedical Equipment
Business model
B2BB2B2C

Tags

infectious-diseasediagnosticsmedical-devices